Drug Interaction Profile of Momelotinib

Trial Profile

Drug Interaction Profile of Momelotinib

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Sep 2015

At a glance

  • Drugs Momelotinib (Primary) ; Midazolam; Rifampicin; Ritonavir; Rosuvastatin
  • Indications Essential thrombocythaemia; Myelofibrosis; Myeloproliferative disorders; Non-small cell lung cancer; Pancreatic cancer; Polycythaemia vera
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 14 Sep 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top